Characterization of circulating APOL1 protein complexes in African Americans

Genovese, 2010, Association of trypanolytic ApoL1 variants with kidney disease in African Americans, Science., 329, 841, 10.1126/science.1193032 Tzur, 2010, Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene, Hum. Genet., 128, 345, 10.1007/s00439-010-0861-0 Freedman, 2010, The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans, J. Am. Soc. Nephrol., 21, 1422, 10.1681/ASN.2010070730 Madhavan, 2011, APOL1 localization in normal kidney and nondiabetic kidney disease, J. Am. Soc. Nephrol., 22, 2119, 10.1681/ASN.2011010069 Ma, 2015, Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines, J. Am. Soc. Nephrol., 26, 339, 10.1681/ASN.2013091017 Duchateau, 1997, Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L, J. Biol. Chem., 272, 25576, 10.1074/jbc.272.41.25576 Gutierrez, 2015, APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans, Nephrol. Dial. Transplant., 272 Ito, 2014, Increased burden of cardiovascular disease in carriers of APOL1 genetic variants, Circ. Res., 114, 845, 10.1161/CIRCRESAHA.114.302347 Detrano, 2008, Coronary calcium as a predictor of coronary events in four racial or ethnic groups, N. Engl. J. Med., 358, 1336, 10.1056/NEJMoa072100 Langefeld, 2015, Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial, Kidney Int., 87, 169, 10.1038/ki.2014.254 Freedman, 2015, APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes, Kidney Int., 87, 176, 10.1038/ki.2014.255 Uzureau, 2013, Mechanism of Trypanosoma brucei gambiense resistance to human serum, Nature., 501, 430, 10.1038/nature12516 Samanovic, 2009, Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection, PLoS Pathog., 5, e1000276, 10.1371/journal.ppat.1000276 Bruggeman, 2014, Plasma apolipoprotein L1 levels do not correlate with CKD, J. Am. Soc. Nephrol., 25, 634, 10.1681/ASN.2013070700 Cheng, 2015, Biogenesis and cytotoxicity of APOL1 renal-risk variant proteins in hepatocytes and hepatoma cells, J. Lipid Res., 56, 1583, 10.1194/jlr.M059733 Mulya, 2007, Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1, Arterioscler. Thromb. Vasc. Biol., 27, 1828, 10.1161/ATVBAHA.107.142455 Thomson, 2014, Evolution of the primate trypanolytic factor APOL1, Proc. Natl. Acad. Sci. USA., 111, E2130, 10.1073/pnas.1400699111 Reeves-Daniel, 2011, The APOL1 gene and allograft survival after kidney transplantation, Am. J. Transplant., 11, 1025, 10.1111/j.1600-6143.2011.03513.x Lee, 2012, The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival, Am. J. Transplant., 12, 1924, 10.1111/j.1600-6143.2012.04033.x Freedman, 2015, Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure, Am. J. Transplant., 15, 1615, 10.1111/ajt.13223 Cheung, 1988, Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subpopulations, J. Lipid Res., 29, 15, 10.1016/S0022-2275(20)38558-8 Kunitake, 1982, Factors affecting the integrity of high density lipoproteins in the ultracentrifuge, J. Lipid Res., 23, 936, 10.1016/S0022-2275(20)38097-4 Havel, 1955, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest., 34, 1345, 10.1172/JCI103182 Kane, 2012, Prebeta-1 HDL and coronary heart disease, Curr. Opin. Lipidol., 23, 367, 10.1097/MOL.0b013e328353eef1 Lee, 2005, ATP-binding cassette transporter AI and its role in HDL formation, Curr. Opin. Lipidol., 16, 19, 10.1097/00041433-200502000-00005 Rosenson, 2012, Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport, Circulation., 125, 1905, 10.1161/CIRCULATIONAHA.111.066589 Cheung, 2010, Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation, Biochemistry., 49, 7314, 10.1021/bi100359f Nielsen, 2006, Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein, Blood., 108, 2846, 10.1182/blood-2006-05-022327 Raper, 1999, Characterization of a novel trypanosome lytic factor from human serum, Infect. Immun., 67, 1910, 10.1128/IAI.67.4.1910-1916.1999 Lugli, 2004, Characterization of primate trypanosome lytic factors, Mol. Biochem. Parasitol., 138, 9, 10.1016/j.molbiopara.2004.07.004 Pays, 2006, The trypanolytic factor of human serum, Nat. Rev. Microbiol., 4, 477, 10.1038/nrmicro1428 Huggins, 2000, Determination of the tissue sites responsible for the catabolism of large high density lipoprotein in the African green monkey, J. Lipid Res., 41, 384, 10.1016/S0022-2275(20)34477-1 Lee, 2005, HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney, J. Lipid Res., 46, 2233, 10.1194/jlr.M500179-JLR200 Gregorini, 2015, Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis, Kidney Int., 87, 1223, 10.1038/ki.2014.389